Ventrinova
About:
VentriNova is revolutionizing cardiac regenerative medicine by reversing cardiac damage pharmacologically.
Website: http://www.ventrinovainc.com/
Top Investors: Broadview Ventures
Description:
VentriNova is a regenerative medicine company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. VentriNova’s first generation product is a gene therapy that delivers a critical mitotic regulator to diseased heart tissue to stimulate proliferation of cardiac muscle cells.
Total Funding Amount:
$1M
Headquarters Location:
New York, New York, United States
Founded Date:
2006-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2009-09-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai